Hexarelin is a synthetic hexapeptide growth hormone secretagogue that binds to the ghrelin receptor (GHS-R1a). It is considered one of the most potent GHRPs available, stimulating greater GH release than GHRH alone. However, it causes relatively rapid receptor desensitization compared to milder GHRPs like ipamorelin, limiting cycle duration to 4-8 weeks. It also has notable cardioprotective properties independent of GH release.
Category: Growth Hormone Secretagogue. Evidence rating: C (early/mixed human evidence).
Clinical status: Phase II completed. Development discontinued due to tolerance/desensitization concerns.
Hexarelin binds to and activates the ghrelin/growth hormone secretagogue receptor (GHS-R1a) in the pituitary and hypothalamus through a triple mechanism: direct stimulation of pituitary somatotroph cells to release stored GH, stimulation of hypothalamic GHRH-releasing neurons, and suppression of…
Research base: 0 registered clinical trials and 22 indexed publications reference Hexarelin.
Safety considerations: Generally well-tolerated in clinical trials; Transient cortisol and prolactin elevation at higher doses; Hunger increase (ghrelin receptor activation).
Reviewed by the PeptideAtlas Editorial Team. Last reviewed: 2026-07-05.
Related peptides: Ipamorelin, CJC-1295, Sermorelin.
Compare: Hexarelin vs Ipamorelin, Hexarelin vs CJC-1295, Hexarelin vs Sermorelin.
Hexarelin is more potent for raw GH release but causes faster receptor desensitization (4-8 weeks vs 8-12+ weeks for ipamorelin). Hexarelin also raises cortisol and prolactin, while ipamorelin is more selective. Ipamorelin is generally preferred for longer-term use; hexarelin for short, intense GH pulses.
Clinical development was stopped due to tolerance development with chronic administration. The receptor desensitization that occurs after 4-8 weeks made it unsuitable as a long-term pharmaceutical, though short-cycle research use remains common.
Hexarelin is considered one of the most potent growth hormone-releasing peptides available, producing significant GH secretion even after repeated administration.
HEXARELIN has been studied for: Potent GH release, Muscle research, Performance studies. Potent GHRP; strongest in class.
Synthetic hexapeptide that strongly activates ghrelin receptors, producing robust and sustained GH release.